Published in Proc Natl Acad Sci U S A on April 01, 1976
Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences. Proc Natl Acad Sci U S A (1982) 2.02
Occupational and other environmental factors and multiple myeloma: a population based case-control study. Br J Ind Med (1992) 1.74
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology (2007) 1.71
Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci U S A (1980) 1.61
Translation of bovine leukemia virus virion RNAs in heterologous protein-synthesizing systems. J Virol (1979) 1.60
Amino-terminal sequence of bovine leukemia virus major internal protein: homology with mammalian type C virus p30 structural proteins. Proc Natl Acad Sci U S A (1979) 1.57
Biochemical and immunological characterization of the major envelope glycoprotein of bovine leukemia virus. J Virol (1977) 1.36
Immunological purification and partial characterization of variant-specific surface antigen messenger RNA of Trypanosoma brucei brucei. Nucleic Acids Res (1979) 1.31
Restriction endonuclease mapping of linear unintegrated proviral DNA of bovine leukemia virus. J Virol (1981) 1.24
Integration of bovine leukemia virus DNA in the bovine genome. Proc Natl Acad Sci U S A (1979) 1.23
The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection. J Virol (1996) 1.19
Case-control study of multiple myeloma and farming. Br J Cancer (1986) 1.18
Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV. Viruses (2011) 1.14
Antiviral activity of shiga toxin 1: suppression of bovine leukemia virus-related spontaneous lymphocyte proliferation. Infect Immun (2000) 1.14
Increased interleukin-10 mRNA expression in tumor-bearing or persistently lymphocytotic animals infected with bovine leukemia virus. J Virol (1996) 1.14
Squirrel monkey retrovirus: an endogenous virus of a new world primate. J Virol (1977) 1.10
Frog oocytes synthesize and completely process the precursor polypeptide to virion structural proteins after microinjection of avian myeloblastosis virus RNA. Proc Natl Acad Sci U S A (1977) 1.08
The pX region of the bovine leukemia virus is transcribed as a 2.1-kilobase mRNA. J Virol (1985) 1.06
Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc Natl Acad Sci U S A (2002) 1.01
Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo. J Virol (2002) 0.98
Purification and characterization of the DNA polymerase of human breast cancer particles. Proc Natl Acad Sci U S A (1977) 0.95
Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus. J Virol (2000) 0.95
Proviral detection and serology in bovine leukemia virus-exposed normal cattle and cattle with lymphoma. Can J Vet Res (1992) 0.94
Molecular evidence for a type C retrovirus etiology of the lymphoproliferative disease of turkeys. J Virol (1979) 0.90
Proteins of bovine leukemia virus. I. Characterization and reactions with natural antibodies. J Virol (1977) 0.89
Animal models on HTLV-1 and related viruses: what did we learn? Front Microbiol (2012) 0.88
Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis. J Virol (1998) 0.88
Evidence that the spontaneous blastogenesis of lymphocytes from bovine leukemia virus-infected cattle is viral antigen specific. Infect Immun (1981) 0.86
Regulation of bovine leukemia virus tax and pol mRNA levels by interleukin-2 and -10. J Virol (1999) 0.82
Epidemiological evaluation of a monoclonal ELISA detecting antibodies against bovine leukaemia virus in serum pools. Epidemiol Infect (1994) 0.82
Cell Infectivity in relation to bovine leukemia virus gp51 and p24 in bovine milk exosomes. PLoS One (2013) 0.81
Embryo transfer in relation to bovine leukemia virus control and eradication. Can Vet J (1985) 0.80
Sequencing and phylogenetic analysis of the gp51 gene from Korean bovine leukemia virus isolates. Virol J (2015) 0.78
Analogie entre les rétrovirus humains lymphotropes et les rétrovirus des grands animaux. Can Vet J (1986) 0.75
Analogy between lymphotropic human retroviruses and large animal retroviruses. Can Vet J (1986) 0.75
Repeated sequences in DNA. Hundreds of thousands of copies of DNA sequences have been incorporated into the genomes of higher organisms. Science (1968) 30.37
RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (1970) 19.89
RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature (1970) 19.38
Purification and further properties of single-strand-specific nuclease from Aspergillus oryzae. Eur J Biochem (1973) 13.54
RNA metabolism of murine leukemia virus: detection of virus-specific RNA sequences in infected and uninfected cells and identification of virus-specific messenger RNA. J Mol Biol (1973) 6.19
Characterization of the products of DNA-directed DNA polymerases in oncogenic RNA viruses. Nature (1970) 5.23
Simultaneous detection of reverse transcriptase and high molecular weight RNA unique to oncogenic RNA viruses. Science (1971) 3.68
Widespread presence, in chickens, of DNA complementary to the RNA genome of avian leukosis viruses. Proc Natl Acad Sci U S A (1972) 3.67
Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J Natl Cancer Inst (1969) 3.64
Forms of deoxyribonucleic acid produced by virions of the ribonucleic acid tumor viruses. J Virol (1971) 3.45
RNA-dependent DNA polymerase activity in five RNA viruses: divalent cation requirements. Proc Natl Acad Sci U S A (1970) 3.25
Appearance of virus-specific DNA in mammalian cells following transformation by Rous sarcoma virus. J Mol Biol (1973) 3.21
Nucleotide sequence relationships of avian RNA tumor viruses: measurement of the deletion in a transformation-defective mutant of Rous sarcoma virus. J Virol (1974) 2.61
Extent of transcription by the RNA-dependent DNA polymerase of Rous sarcoma virus. Nat New Biol (1971) 2.36
Purification, characterization, and comparison of the DNA polymerases from two primate RNA tumor viruses. J Virol (1973) 2.34
Replicating C-type virus in phytohemagglutinin-treated buffy-coat cultures of bovine origin. J Natl Cancer Inst (1972) 1.51
Presence in leukemic cells of avian myeloblastosis virus-specific DNA sequences absent in normal chicken cells. J Virol (1974) 1.32
Nuclear DNA sequences present in human leukemic cells and absent in normal leukocytes. Proc Natl Acad Sci U S A (1972) 1.32
Precipitating antibody to an internal antigen of the C-type virus associated with bovine lymphosarcoma. J Natl Cancer Inst (1972) 1.30
Deoxyribonucleic acid polymerase of Rous sarcoma virus: reaction conditions and analysis of the reaction product nucleic acids. J Virol (1971) 1.29
Replicating type-C virus particles in monolayer cell cultures of tissues from cattle with lymphosarcoma. J Natl Cancer Inst (1974) 1.27
Comparative biochemical properties of RNA-directed DNA polymerases from Rauscher murine leukemia virus and avian myeloblastosis virus. Cancer Res (1974) 1.24
PEDIGREE STUDIES IN BOVINE LYMPHOSARCOMA. Ann N Y Acad Sci (1963) 1.23
Biochemical properties of the bromodeoxyuridine-induced guinea pig virus. J Virol (1975) 1.22
Chicken leukosis virus genome sequences in DNA from normal chick cells and virus-induced bursal lymphomas. Cell (1975) 1.22
The presence of unique DNA sequences after viral induction of leukemia in mice. (RNA tumor virus-nucleic acid hybridization-insertion of viral DNA). Proc Natl Acad Sci U S A (1974) 1.19
Transmission of lymphosarcoma from cattle to sheep. J Natl Cancer Inst (1972) 1.19
Serological detection of type C viruses found in bovine cultures. Cancer Res (1972) 1.16
RNA processing and RNA tumor virus origin and evolution. Science (1975) 1.13
Inoculation of calves with particles resembling C-type virus from cultures of bovine lymphosarcoma. J Natl Cancer Inst (1972) 1.12
Leukemia-specific DNA sequences in leukocytes of the leukemic member of identical twins. Proc Natl Acad Sci U S A (1973) 1.08
Evidence of bovine C-type (leukemia) virus in dairy cattle. J Am Vet Med Assoc (1973) 1.04
A complement-fixation test for the bovine leukemia (C-type) virus. J Natl Cancer Inst (1974) 1.04
Separation of B and C type virions by centrifugation in gentle density gradients. J Virol (1974) 1.02
Viral-related DNA sequences before and after transformation by RNA tumor viruses. Int J Cancer (1973) 0.91
Structure of C-type virus particles in lymphocyte cultures of bovine origin. J Natl Cancer Inst (1974) 0.84
Studies on the relationship between persistent lymphocytosis, infection with C-type particles and presence of Trypanosoma theileri, associated with bovine enzootic leukosis. Zentralbl Veterinarmed B (1975) 0.83
[Etiology of bovine leukosis. 8. Attempts at transmission to lambs using the blood of leukotic cattle (short report)]. Arch Exp Veterinarmed (1969) 0.82
Antibodies to common ovine and bovine C-type virus specific antigen in serum from sheep with spontaneous leukosis and from inoculated animals. Med Microbiol Immunol (1974) 0.80
The composite genome of the legume symbiont Sinorhizobium meliloti. Science (2001) 9.11
The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature (1987) 7.06
Purification of the DNA polymerase of avian myeloblastosis virus. Biochim Biophys Acta (1971) 6.64
Characterization of the products of DNA-directed DNA polymerases in oncogenic RNA viruses. Nature (1970) 5.23
DNA-directed DNA polymerase activity in oncogenic RNA viruses. Nature (1970) 4.81
A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science (1997) 4.29
Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science (1986) 4.04
Synthetic DNA-RNA hybrids and RNA-RNA duplexes as templates for the polymerases of the oncogenic RNA viruses. Nature (1970) 3.98
Complete DNA sequence of yeast chromosome XI. Nature (1994) 3.51
The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J (1989) 3.50
HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J (1999) 3.10
One-step purification of mouse monoclonal antibodies from ascitic fluid by DEAE Affi-Gel blue chromatography. J Immunol Methods (1982) 3.06
Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J (1993) 2.91
Analysis of the chromosome sequence of the legume symbiont Sinorhizobium meliloti strain 1021. Proc Natl Acad Sci U S A (2001) 2.83
The gag and pol genes of bovine leukemia virus: nucleotide sequence and analysis. Virology (1985) 2.53
Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene (1994) 2.45
Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics (1996) 2.34
Cooperative binding of Ets-1 and core binding factor to DNA. Mol Cell Biol (1994) 2.27
[Isolation of messenger RNA from rabbit reticulocytes]. Biochim Biophys Acta (1965) 2.25
DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol (1994) 2.18
A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. Mol Endocrinol (1989) 2.16
The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature (1988) 2.16
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12
Homologous tyrosine phosphorylation sites in transformation-specific gene products of distinct avian sarcoma viruses. Nature (1981) 2.11
The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1. EMBO J (1990) 2.03
Tyrosine-specific protein kinase activity associated with p105 of avian sarcoma virus PRCII. Virology (1981) 2.03
Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences. Proc Natl Acad Sci U S A (1982) 2.02
Identification in chickens of an evolutionarily conserved cellular ets-2 gene (c-ets-2) encoding nuclear proteins related to the products of the c-ets proto-oncogene. EMBO J (1988) 1.99
The nucleotide sequence of the env gene and post-env region of bovine leukemia virus. Virology (1984) 1.98
Identification and preferential expression in thymic and bursal lymphocytes of a c-ets oncogene-encoded Mr 54,000 cytoplasmic protein. Proc Natl Acad Sci U S A (1986) 1.89
Identification of nucleotide preferences in DNA sequences recognised specifically by c-Ets-1 protein. Nucleic Acids Res (1992) 1.82
Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. Mol Cell Biol (1992) 1.81
Class IIa histone deacetylases: regulating the regulators. Oncogene (2007) 1.78
Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers. Mol Endocrinol (1992) 1.71
In vivo infection of sheep by bovine leukemia virus mutants. J Virol (1993) 1.69
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A (1998) 1.68
Electron microscopical studies on the localisation of the different components of cell walls of gram-negative bacteria. Folia Microbiol (Praha) (1967) 1.68
Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells. Science (1985) 1.67
DNA polymerase activities in varions of visna virus, a causative agent of a "slow" neurological disease. Proc Natl Acad Sci U S A (1971) 1.67
Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro. Mol Cell Biol (1989) 1.67
Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51. J Virol Methods (1989) 1.66
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. J Hum Virol (1999) 1.65
Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci U S A (1980) 1.61
A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein. EMBO J (1997) 1.60
Translation of bovine leukemia virus virion RNAs in heterologous protein-synthesizing systems. J Virol (1979) 1.60
The chemical composition of idiopathic nonarteriosclerotic cerebral calcifications. Neurology (1975) 1.59
Experiments with cloned complete tumor-derived bovine leukemia virus information prove that the virus is totally exogenous to its target animal species. J Virol (1981) 1.58
Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor. J Virol (1993) 1.58
Mitogenic stimulation of thymocytes results in the calcium-dependent phosphorylation of c-ets-1 proteins. EMBO J (1988) 1.58
C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci U S A (1998) 1.57
Synergistic activation of the HTLV1 LTR Ets-responsive region by transcription factors Ets1 and Sp1. EMBO J (1993) 1.57
GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol (1993) 1.57
An immunophilin that binds M(r) 90,000 heat shock protein: main structural features of a mammalian p59 protein. Proc Natl Acad Sci U S A (1992) 1.56
Characterization of the messenger ribonucleoprotein released from reticulocyte polyribosomes by EDTA treatment. Eur J Biochem (1971) 1.56
Genomic integration of bovine leukemia provirus and lack of viral RNA expression in the target cells of cattle with different responses to BLV infection. Leuk Res (1980) 1.53
Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood (2000) 1.52
Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles. Virology (1993) 1.52
Absence of polyadenylate segment in globin messenger RNA accelerates its degradation in Xenopus oocytes. Proc Natl Acad Sci U S A (1975) 1.51
The bovine leukemia virus p34 is a transactivator protein. EMBO J (1987) 1.48
Expression of the v-erbA oncogene in chicken embryo fibroblasts stimulates their proliferation in vitro and enhances tumor growth in vivo. Cell (1987) 1.46
A phorbol ester response element within the human T-cell receptor beta-chain enhancer. Proc Natl Acad Sci U S A (1992) 1.44
Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J (1990) 1.44
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc Natl Acad Sci U S A (2000) 1.42
Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene (1994) 1.40
Readenylation of polyadenylate-free globin messenger RNA restores its stability in vivo. Eur J Biochem (1975) 1.40
TEL is a sequence-specific transcriptional repressor. J Biol Chem (1999) 1.39
Isolation of the mouse mammary tumor virus sequences not transmitted as germinal provirus in the C3H and RIII mouse strains. J Virol (1977) 1.39
Bovine leukemia virus, an animal model for the study of intrastrain variability. J Virol (1993) 1.38
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients. J Hum Virol (1999) 1.38
Neutralization of poliovirus by antibody-mediated polymerization. Virology (1983) 1.38